1
/
of
1
Elabscience
SKU:PKSH030869
Recombinant Human SIGLEC3/CD33 Protein (His Tag)
Recombinant Human SIGLEC3/CD33 Protein (His Tag)
Regular price
$732.00 USD
Regular price
Sale price
$732.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human SIGLEC3/CD33 Protein (His Tag), a cutting-edge product meticulously engineered to meet the highest standards of quality and performance. This protein, derived from human sources, exhibits a remarkable affinity for the SIGLEC3/CD33 receptor, making it an invaluable tool for researchers and scientists in various fields.
With its His Tag, this recombinant protein offers enhanced stability and ease of purification, ensuring optimal results in experimental settings. Its exceptional purity and bioactivity guarantee accurate and reliable outcomes, enabling precise investigations into the intricate mechanisms involving the SIGLEC3/CD33 receptor.
The Recombinant Human SIGLEC3/CD33 Protein (His Tag) is manufactured using state-of-the-art techniques, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure consistency and reliability, providing researchers with a consistent and dependable resource for their studies.
This product is supplied in a lyophilized form, preserving its integrity and extending its shelf life. Upon reconstitution, the protein retains its full functionality, allowing for immediate utilization in a wide range of applications, including but not limited to protein-protein interaction studies, drug discovery, and therapeutic development.
We take pride in offering this exceptional product, which has been meticulously designed to meet the demands of the scientific community. With its unparalleled quality, stability, and bioactivity, the Recombinant Human SIGLEC3/CD33 Protein (His Tag) is poised to revolutionize research in the field, empowering scientists to unravel the complexities of the SIGLEC3/CD33 receptor and pave the way for groundbreaking discoveries.
Choose the Recombinant Human SIGLEC3/CD33 Protein (His Tag) and unlock the potential of your research, as you delve into the intricate world of cellular interactions and signaling pathways. Experience the pinnacle of scientific excellence with this remarkable protein, and embark on a journey of discovery like never before.
With its His Tag, this recombinant protein offers enhanced stability and ease of purification, ensuring optimal results in experimental settings. Its exceptional purity and bioactivity guarantee accurate and reliable outcomes, enabling precise investigations into the intricate mechanisms involving the SIGLEC3/CD33 receptor.
The Recombinant Human SIGLEC3/CD33 Protein (His Tag) is manufactured using state-of-the-art techniques, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure consistency and reliability, providing researchers with a consistent and dependable resource for their studies.
This product is supplied in a lyophilized form, preserving its integrity and extending its shelf life. Upon reconstitution, the protein retains its full functionality, allowing for immediate utilization in a wide range of applications, including but not limited to protein-protein interaction studies, drug discovery, and therapeutic development.
We take pride in offering this exceptional product, which has been meticulously designed to meet the demands of the scientific community. With its unparalleled quality, stability, and bioactivity, the Recombinant Human SIGLEC3/CD33 Protein (His Tag) is poised to revolutionize research in the field, empowering scientists to unravel the complexities of the SIGLEC3/CD33 receptor and pave the way for groundbreaking discoveries.
Choose the Recombinant Human SIGLEC3/CD33 Protein (His Tag) and unlock the potential of your research, as you delve into the intricate world of cellular interactions and signaling pathways. Experience the pinnacle of scientific excellence with this remarkable protein, and embark on a journey of discovery like never before.
Share
